Ticker HubNYSE

KVUE

Kenvue Inc.

PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS

Latest price

$19.49-0.41%

As of Oct 26, 2026, 6:46 PM EDT · Market data by Massive

Market cap

$37.6B

Volume

9.5M

Previous close

$19.57

Day range

$19.40 – $19.75

Listed

May 4, 2023

Coverage

1 article

Price performance

Recent trading

5 trading days · 15-minute intervals · ET

Five-day open $18.92Latest interval $19.49

Newsroom

Latest KVUE coverage

BusinessCompanyApr 2, 2025

Kenvue Under Pressure: TOMS Capital Pushes for Bold Moves Amid Operational Overhaul

In a surprising turn of events, TOMS Capital Investment Management has taken a stake in Kenvue and is now pressuring the company to consider a full sale or the separation of certain assets.

KVUE

Company overview

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.

Industry: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
Employees: 22K
Headquarters: SUMMIT, NJ
CIK: 0001944048

Company website View advanced chart

SEC filings

No filing records are attached to this profile yet.

Browse EDGAR

Profile at a glance

May 4, 2023

Listed

22K

Employees

Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.